Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01342523 · ClinicalTrials.gov registry record · Phase 4

Evaluation of National Cancer Institute (NCI) Smoking Intervention Resources

A Phase 4 study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
Phase 4
Development phase
1,034
Enrollment target

NCT01342523 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 1,034 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01342523, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
Phase 4
Development phase
1,034 participants
Enrollment target

Study Summary

This is an evaluative study of three National Cancer Institute (NCI) smoking cessation resources: specifically, the smokefree.gov and women smokefree.gov websites, and the CIS counseling phone calls. The following are the identified critical questions: (1). How effective is each of the tobacco interventions (websites \[smokefree.gov \& women smokefree.gov\], NCI's Cessation Quitline counseling services operated by the Cancer Information Service (CIS) (2). How do they compare with alternative intervention strategies? (3). Which types of interventions appear to work best together (due to additive or interactive effects)? (4). How do these interventions work? (5). How much are these interventions used, and what are their relative use rates? (6). Are there important differences in effectiveness or use rates as a function of gender, SES, or other important person factors? We believe that the research study will address all of these questions, as well as some less central ones.

Interventions

  • OTHER CIS - telephone cessation quitline counseling
  • OTHER Lozenge - nicotine mini-lozenges
  • OTHER Emails - Brief smoking prevention messages
  • OTHER Full website - standard smokefree.gov website content
  • OTHER Lite website - lite version of smokefree.gov

Trial Details

FieldValue
Enrollment Target 1,034 participants
Start Date 2011-10
Est. Completion 2013-10
Phase Phase 4

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT01342523

The ClinicalTrials.gov registry entry for NCT01342523 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,034 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which CIS - telephone cessation quitline counseling is the first listed.

NCT01342523 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01342523 about?

NCT01342523 is a clinical study titled "Evaluation of National Cancer Institute (NCI) Smoking Intervention Resources". This is an evaluative study of three National Cancer Institute (NCI) smoking cessation resources: specifically, the smokefree.gov and women smokefree.gov websites, and the CIS counseling phone calls. The following are the identified critical questions: (1). How effective is each of the tobacco inter...

What is the current status of trial NCT01342523?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,034 participants. The study started on 2011-10. Estimated completion is 2013-10.

What interventions are being tested in trial NCT01342523?

The interventions under investigation include: CIS - telephone cessation quitline counseling (OTHER), Lozenge - nicotine mini-lozenges (OTHER), Emails - Brief smoking prevention messages (OTHER), Full website - standard smokefree.gov website content (OTHER), Lite website - lite version of smokefree.gov (OTHER).

Who is sponsoring clinical trial NCT01342523?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.